As of Mar 24
| +0.99 / +0.95%|
The 5 analysts offering 12-month price forecasts for Ligand Pharmaceuticals Inc have a median target of 120.00, with a high estimate of 160.00 and a low estimate of 100.00. The median estimate represents a +14.53% increase from the last price of 104.78.
The current consensus among 5 polled investment analysts is to Buy stock in Ligand Pharmaceuticals Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.